Saturday, July 11, 2026

Samsung Bioepis Launches SBE303: The First ADC Drug Candidate Targeting Nectin-4 in Cancer Trials

Samsung Bioepis has begun Phase 1 trials for its ADC candidate SBE303, targeting solid tumors, set to continue until July 2030.

THE ONE TRILLION FANTASY: Lee’s Gov’t Throws $1 Billion At A Unification Dream Kim Jong Un Doesn’t Want

The Lee Jae Myung administration boosts the inter-Korean cooperation fund by 200 billion KRW to enhance dialogue and economic cooperation.

Tag: Interactive Exhibits

No posts to display

Top News

- Our Sponsors Ad -

Follow us